The cell proliferation rate, as measured by the percentage of Ki-67+ tumor cells, was increased in tumors from the miR-133a-3p-knockdown xenografts and decreased in tumors from the MAML1-knockdown xenografts. Here, MAML1 is linked to neoplasm.